US Broker Ratings

Doximity, Inc. (DOCS) Stock Analysis: Potential 55% Upside Amid Robust Revenue Growth

Doximity, Inc. (NYSE: DOCS), a leader in digital health information services, is positioning itself as a compelling investment opportunity within the healthcare sector. With a market..

HealthEquity, Inc. (HQY) Investor Outlook: A 26.84% Upside Potential Awaits

As the healthcare sector continues to evolve, HealthEquity, Inc. (NASDAQ: HQY) stands out as a key player with a promising forecast. With a market capitalization of..

Grifols, S.A. (GRFS) Valuation Insights: Exploring a Potential 23% Upside for Investors

As a significant player in the healthcare sector, Grifols, S.A. (GRFS) is known for its robust portfolio of plasma-derived therapies and diagnostic solutions. With its operations..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Its 11.61% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices industry, is capturing investor attention with its attractive growth potential and a solid..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Biotechnology Leader with 22.91% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) presents a compelling opportunity for investors seeking exposure to the innovative field of biotechnology. With a market capitalization of $52.88 billion,..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Evaluating the 16.83% Upside Potential in the Biotech Sector

Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based clinical-stage biopharmaceutical company, stands at the frontier of innovative drug discovery and development. With a market capitalization of $15.59..

Ascendis Pharma A/S (ASND) Investor Outlook: Analyzing a 269% Revenue Growth in the Biotech Space

Ascendis Pharma A/S (NASDAQ: ASND), a cutting-edge player in the biotechnology sector, is captivating investor attention with its remarkable revenue growth of 269.4% amidst an evolving..

Danaher Corporation (DHR) Stock Analysis: Why a 14.79% Potential Upside Might Capture Investor Attention

Danaher Corporation (NYSE: DHR) stands as a formidable entity in the healthcare sector, specifically within the diagnostics and research industry. With a significant market capitalization of..

DexCom, Inc. (DXCM)

⚠️ No article content returned.

..

STERIS plc (STE) Stock Analysis: 10.73% Potential Upside and Strong Revenue Growth Draw Investors’ Attention

Investors seeking opportunities in the healthcare sector may find STERIS plc (NYSE: STE) an intriguing prospect. With its roots in infection prevention products and services, STERIS..

The Cigna Group (CI) Stock Analysis: A Closer Look at Its 19.5% Potential Upside

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, commands attention with its robust position in the healthcare plans industry. With a market capitalization..

AstraZeneca PLC (AZN) Stock Analysis: Strong Buy Ratings and 8.31% Upside Potential

AstraZeneca PLC (AZN) is a powerhouse in the healthcare sector, standing out as a leader in the drug manufacturing industry. With a market capitalization of $283.27..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 14.23% Potential Upside in the Healthcare Sector

For investors seeking to expand their portfolios within the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) presents an interesting opportunity. As a leading player in..

Becton, Dickinson and Company (BDX): Investor Outlook Reveals 4.13% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its expansive portfolio in medical instruments and supplies...

Exelixis, Inc. (EXEL) Stock Analysis: Navigating the Biotech Frontier with a Strong R&D Pipeline and Robust Revenue Growth

Exelixis, Inc. (NASDAQ: EXEL) stands as a formidable player in the biotechnology sector, with a strategic focus on oncology. As a leading innovator in the development..

BioMarin Pharmaceutical Inc. (BMRN): Analyzing a Promising 44.48% Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a major player in the biotechnology sector, is capturing investor attention with its significant growth potential and a robust pipeline of..

Cardinal Health (CAH) Stock Analysis: Unpacking Its 6.73% Potential Upside and Robust Revenue Growth

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, has been capturing investor attention with its robust operational performance and promising stock potential...

ICON plc (ICLR) Stock Analysis: Unveiling an 18.76% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), headquartered in Dublin, Ireland, is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company offers..

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 25% Upside Potential in Healthcare Innovation

Investors exploring opportunities in the medical devices industry should take a closer look at Koninklijke Philips N.V. (PHG), a prominent player in the healthcare sector based..

IDEXX Laboratories (IDXX) Stock Analysis: Examining Growth Potential with a 9.38% Upside

Investors with a keen eye on the healthcare sector should certainly take note of IDEXX Laboratories, Inc. (NASDAQ: IDXX). This industry leader in diagnostics and research,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds